BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21939488)

  • 1. Characteristics and clinical significance of prostate cancers missed by initial transrectal 12-core biopsy.
    Numao N; Kawakami S; Sakura M; Yoshida S; Koga F; Saito K; Masuda H; Fujii Y; Yamamoto S; Yonese J; Ishikawa Y; Fukui I; Kihara K
    BJU Int; 2012 Mar; 109(5):665-71. PubMed ID: 21939488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies.
    Dimmen M; Vlatkovic L; Hole KH; Nesland JM; Brennhovd B; Axcrona K
    BJU Int; 2012 Jul; 110(2 Pt 2):E69-75. PubMed ID: 22093091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy.
    Komai Y; Numao N; Yoshida S; Matsuoka Y; Nakanishi Y; Ishii C; Koga F; Saito K; Masuda H; Fujii Y; Kawakami S; Kihara K
    J Urol; 2013 Sep; 190(3):867-73. PubMed ID: 23542406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study.
    Djavan B; Mazal P; Zlotta A; Wammack R; Ravery V; Remzi M; Susani M; Borkowski A; Hruby S; Boccon-Gibod L; Schulman CC; Marberger M
    Prostate; 2001 May; 47(2):111-7. PubMed ID: 11340633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved accuracy in predicting the presence of Gleason pattern 4/5 prostate cancer by three-dimensional 26-core systematic biopsy.
    Numao N; Kawakami S; Yokoyama M; Yonese J; Arisawa C; Ishikawa Y; Ando M; Fukui I; Kihara K
    Eur Urol; 2007 Dec; 52(6):1663-8. PubMed ID: 17240041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal sampling sites for repeat prostate biopsy: a recursive partitioning analysis of three-dimensional 26-core systematic biopsy.
    Kawakami S; Okuno T; Yonese J; Igari T; Arai G; Fujii Y; Kageyama Y; Fukui I; Kihara K
    Eur Urol; 2007 Mar; 51(3):675-82; discussion 682-3. PubMed ID: 16843585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.
    Tan N; Lane BR; Li J; Moussa AS; Soriano M; Jones JS
    J Urol; 2008 Oct; 180(4):1325-9; discussion 1329. PubMed ID: 18707706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate biopsy: who, how and when. An update.
    Djavan B; Milani S; Remzi M
    Can J Urol; 2005 Feb; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy.
    Hara R; Jo Y; Fujii T; Kondo N; Yokoyoma T; Miyaji Y; Nagai A
    Urology; 2008 Feb; 71(2):191-5. PubMed ID: 18308081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Location and pathological characteristics of cancers in radical prostatectomy specimens identified by transperineal biopsy compared to transrectal biopsy.
    Hossack T; Patel MI; Huo A; Brenner P; Yuen C; Spernat D; Mathews J; Haynes AM; Sutherland R; del Prado W; Stricker P
    J Urol; 2012 Sep; 188(3):781-5. PubMed ID: 22819419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The number of cores positive for high grade prostatic intraepithelial neoplasia on initial biopsy is associated with prostate cancer on second biopsy.
    De Nunzio C; Trucchi A; Miano R; Stoppacciaro A; Fattahi H; Cicione A; Tubaro A
    J Urol; 2009 Mar; 181(3):1069-74; discussion 1074-5. PubMed ID: 19150546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy.
    Campos-Fernandes JL; Bastien L; Nicolaiew N; Robert G; Terry S; Vacherot F; Salomon L; Allory Y; Vordos D; Hoznek A; Yiou R; Patard JJ; Abbou CC; de la Taille A
    Eur Urol; 2009 Mar; 55(3):600-6. PubMed ID: 18597923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cancers detected at only a sextant or alternative location.
    Ochiai A; Troncoso P; Babaian RJ
    BJU Int; 2008 Apr; 101(7):837-40. PubMed ID: 18070187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saturation technique does not decrease cancer detection during followup after initial prostate biopsy.
    Lane BR; Zippe CD; Abouassaly R; Schoenfield L; Magi-Galluzzi C; Jones JS
    J Urol; 2008 May; 179(5):1746-50; discussion 1750. PubMed ID: 18343412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are repeat biopsies required in men with PSA levels < or =4 ng/ml? A Multiinstitutional Prospective European Study.
    Djavan B; Fong YK; Ravery V; Remzi M; Horninger W; Susani M; Kreuzer S; Boccon-Gibod L; Bartsch G; Marberger M
    Eur Urol; 2005 Jan; 47(1):38-44; discussion 44. PubMed ID: 15582247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?
    Djavan B; Ravery V; Zlotta A; Dobronski P; Dobrovits M; Fakhari M; Seitz C; Susani M; Borkowski A; Boccon-Gibod L; Schulman CC; Marberger M
    J Urol; 2001 Nov; 166(5):1679-83. PubMed ID: 11586201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications of transrectal versus transperineal prostate biopsy.
    Miller J; Perumalla C; Heap G
    ANZ J Surg; 2005; 75(1-2):48-50. PubMed ID: 15740517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional 26-core biopsy-based patient selection criteria for nerve-sparing radical prostatectomy.
    Numao N; Kawakami S; Yonese J; Koga F; Saito K; Fujii Y; Ishikawa Y; Fukui I; Kihara K
    Int J Urol; 2008 Dec; 15(12):1061-6. PubMed ID: 19120514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial extended transrectal prostate biopsy--are more prostate cancers detected with 18 cores than with 12 cores?
    Scattoni V; Roscigno M; Raber M; Dehò F; Maga T; Zanoni M; Riva M; Sangalli M; Nava L; Mazzoccoli B; Freschi M; Guazzoni G; Rigatti P; Montorsi F
    J Urol; 2008 Apr; 179(4):1327-31; discussion 1331. PubMed ID: 18289580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy.
    Scattoni V; Raber M; Abdollah F; Roscigno M; Dehò F; Angiolilli D; Maccagnano C; Gallina A; Capitanio U; Freschi M; Doglioni C; Rigatti P; Montorsi F
    Eur Urol; 2010 Jan; 57(1):1-8. PubMed ID: 19720449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.